Ausgabe 6/2016
Inhalt (8 Artikel)
Current Opinion
Biosimilar DMARDs: What Does the Future Hold?
Filipe Araújo, João Gonçalves, João Eurico Fonseca
Leading Article
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date
Till Seiler, Grit Hutter, Martin Dreyling
Review Article
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
Maria D. Donovan, Brendan T. Griffin, Liudmila Kharoshankaya, John F. Cryan, Geraldine B. Boylan
Review Article
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis
Ennio Lubrano, Fabio Massimo Perrotta
Adis Drug Evaluation
Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures
Matt Shirley, Sohita Dhillon
Erratum
Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion
R. Vellucci, G. Fanelli, R. Pannuti, C. Peruselli, S. Adamo, G. Alongi, F. Amato, L. Consoletti, L. Lamarca, S. Liguori, C. Lo Presti, A. Maione, S. Mameli, F. Marinangeli, S. Marulli, V. Minotti, D. Miotti, L. Montanari, G. Moruzzi, S. Palermo, M. Parolini, P. Poli, W. Tirelli, A. Valle, P. Romualdi